Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 986 Print this page  Email this page Small font size Default font size Increase font size
Year : 2016  |  Volume : 31  |  Issue : 3  |  Page : 176-178

Therapeutic applications of radioactive 131iodine: Procedures and incidents with capsules

1 Department of Nuclear Medicine, Royal Hospital, Muscat, Sultanate of Oman
2 Medical Physics Unit, National Oncology Centre, Royal Hospital, Muscat, Sultanate of Oman
3 Department of Radiotherapy, National Oncology Center, Royal Hospital, Muscat, Sultanate of Oman
4 Department of Nuclear Medicine, National Oncology Center, Royal Hospital, Muscat, Sultanate of Oman

Correspondence Address:
Ramamoorthy Ravichandran
Medical Physics Unit, National Oncology Centre, Royal Hospital, P.O. Box: 1331, PC 111, Muscat
Sultanate of Oman
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-3919.183603

Rights and Permissions

Background: Treatments for thyrotoxicosis and carcinoma thyroid are carried out by oral administration of radioactive iodine (131I) in the form of liquid or capsules. The liquid form of 131I has higher risk factors such as vapourization, spillage and need for management of higher activity wastes. Use of 131I in capsule form simplify procedures of handling compared to liquid form of 131I. The guidelines of safe handling and quality assurance aspects for therapeutic use 131I are well outlined by International Atomic Energy Agency (IAEA) reports. Aim: A few unusual incidents with I-131 capsules encountered in the past need to be highlighted from health physics point of view. Materials and Methods: In Royal Hospital, Oman, I-131 is imported in capsules, and the total activity handled/year steadily increased over 10 years. Discrete activities range from 185 MBq (5 mCi) up to 7.4 GBq (200 mCi). In four incidents deviations in standard operational procedures were recorded. Results: Nature of incidents is described as follows: (1) After assay of activity, the capsule was directly put in the lead container with missing of inner cap. (2) Patient poured water in the Perspex tube, when the capsule was handed over to her, making an emergency situation. (3) In 3 high activity capsules (2 nos 2.96 GBq, 1 no. 4.26 GBq), observed sticky behavior in capsule holder on the 2nd day post receipt, which were in order on the 1st day. (4) A capsule could not be swallowed by a patient, which was taken back from the mouth. Monitoring of patient later did not show residual ingested activity. Conclusions: The report documents some of the unusual incidents for information to other centers engaged in such radioactive administrations.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded278    
    Comments [Add]    
    Cited by others 2    

Recommend this journal